Invention Grant
- Patent Title: 3,8-diaminotetrahydroquinoline derivative
- Patent Title (中): 3,8-二氨基四氢喹啉衍生物
-
Application No.: US13617469Application Date: 2012-09-14
-
Publication No.: US08501772B2Publication Date: 2013-08-06
- Inventor: Takeshi Watanabe , Masaru Terauchi , Masaaki Nagasawa , Kouichirou Tanaka , Masataka Washiduka
- Applicant: Takeshi Watanabe , Masaru Terauchi , Masaaki Nagasawa , Kouichirou Tanaka , Masataka Washiduka
- Applicant Address: JP Tokyo
- Assignee: Zeria Pharmaceutical Co., Ltd.
- Current Assignee: Zeria Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2008-029781 20080208; JP2008-277044 20081028
- Main IPC: A61K31/4709
- IPC: A61K31/4709

Abstract:
A method for treatment of a systemic wasting disease, by administering, to a subject in need thereof, an effective amount of a 3,8-diaminotetrahydroquinoline derivative represented by formula (Ia) (wherein X represents CH2, C═O, CH—OR, CH—SR, or CH—NRR′; m is a number of 1 or 2; Ar represents a phenyl group, a naphthyl group, a 5-membered or 6-membered aromatic heterocyclic group having one or two elements selected from S, N, and O, or a similar group; R1 and R2, which may be identical to or different from each other, each represent a hydrogen atom or a methyl group; R3 represents a C1 to C6 alkyl group or a similar group; n is a number of 0 or 1; R4 and R5, which may be identical to or different from each other, each represent a hydrogen atom, or a C1 to C6 alkyl group, etc.; and R6, R7, R, and R′, which may be identical to or different from one another, each represent a hydrogen atom or a C1 to C6 alkyl group), or a salt thereof.
Public/Granted literature
- US20130012537A1 3,8-DIAMINOTETRAHYDROQUINOLINE DERIVATIVE Public/Granted day:2013-01-10
Information query
IPC分类: